• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Aid Agencies Hail Agreement On Access To Early Infant HIV Diagnostic Technologies

21/07/2015 by Rishi Dhir for Intellectual Property Watch Leave a Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

An agreement entered into by a range of international organisations and others and announced this week is expected to lower the price of early infant HIV diagnostic technologies by 35 percent, according to the parties.

Community Health Workers Working with HIV-infected Mothers, photo credit USAID

Community Health Workers Working with HIV-infected Mothers, photo credit USAID

“This agreement with Roche Diagnostics is a powerful step towards ending the unconscionable failure of the world to meet the treatment needs of children living with HIV,” UNAIDS Executive Director Michel Sidibé, said in a release. “We now need to use this agreement to rapidly scale up diagnostic and treatment services for all children living with HIV, in line with the 90-90-90 target.”

The 90-90-90 target provides that by 2020, 90 percent of all people living with HIV will know their HIV status; 90 percent of all people with an HIV diagnosis will receive sustained antiretroviral therapy; and 90 percent of all people receiving antiretroviral therapy will achieve viral suppression, the press release said.

The agreement was not made available as of press time.

Global partners in the Diagnostics Access Initiative, which was launched in July 2014, were part of the negotiations. These included UNAIDS, the Clinton Health Access Initiative Inc., the United States President’s Emergency Plan for AIDS Relief, UNITAID, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Following the agreement, the new access price will be USD 9.40 per test for diagnosing HIV in early infants. Despite the World Health Organization’s recommendation that all children exposed to HIV receive early infant diagnostic screening within the first two months of life, in part due to high cost, only around half of the children actually receive the diagnostic screening.

This is the second major price reduction agreement that the Diagnostics Access Initiative has entered into with Roche Diagnostics, first one being in 2014.

The announcement comes as the IAS annual conference is taking place in Vancouver.

Rishi Dhir is an intern at Intellectual Property Watch. He holds a Juris Doctor with honours from the University of Ottawa, Faculty of Law. He also holds dual Bachelor Honour Degrees in Mathematics and Business Administration from the University of Waterloo and Wilfrid Laurier University. Rishi has an interest in a variety of IP issues including copyright law, piracy and Internet governance.

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Rishi Dhir may be reached at info@ip-watch.ch.

Creative Commons License"Aid Agencies Hail Agreement On Access To Early Infant HIV Diagnostic Technologies" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.